Used in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting enzyme inhibitors. Its structure supports development of chiral intermediates for drug candidates, especially in treatments involving metabolic and inflammatory pathways. The fluorine and sulfonyl groups enhance binding selectivity and stability, making it valuable in optimizing pharmacokinetic properties of new therapeutic agents.